BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26411427)

  • 1. Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.
    Ramachandran R; Doddi P; Nandakrishna B; Nada R; Kumar V; Rathi M; Kohli HS; Jha V; Sakhuja V; Gupta KL
    Int Urol Nephrol; 2015 Nov; 47(11):1917-8. PubMed ID: 26411427
    [No Abstract]   [Full Text] [Related]  

  • 2. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
    Tumlin JA; Lohavichan V; Hennigar R
    Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
    Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
    Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
    Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
    Tumlin JA; Hennigar RA
    Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
    Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide.
    Mitsuiki K; Harada A; Okura T; Higaki J
    Clin Exp Nephrol; 2007 Dec; 11(4):297-303. PubMed ID: 18085391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillaritis in IgA nephropathy.
    Ferrario F; Napodano P; Rastaldi MP; D'Amico G
    Contrib Nephrol; 1995; 111():8-12. PubMed ID: 7758350
    [No Abstract]   [Full Text] [Related]  

  • 10. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
    Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
    Kawasaki Y; Hosoya M; Suzuki J; Onishi N; Takahashi A; Isome M; Nozawa R; Suzuki H
    Am J Nephrol; 2004; 24(6):576-81. PubMed ID: 15550753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Randomized controlled clinical trials for IgA nephropathies].
    Yoshikawa T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():123-9. PubMed ID: 17899839
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Kitamura K
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1301-7. PubMed ID: 18508946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of vasculitic IgA nephropathy.
    Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
    J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant therapy with prednisolone and cyclophosphamide in 17 cases with IgA nephropathy.
    Katsumata Y; Hasegawa K; Hoshino K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):295-302. PubMed ID: 4021193
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
    Hwang YC; Lee TW; Kim MJ; Yang MH; Ihm CG
    Korean J Intern Med; 2001 Jun; 16(2):105-9. PubMed ID: 11590896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
    Miyamae T; Nakasima S; Imagawa T; Ito S; Katakura S; Tomono N; Mori M; Ibe M; Mitsuda T; Aihara Y; Yokota S
    Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.